Valuation : Provexis plc

Market Cap 2.52Cr 3.41Cr 2.94Cr 2.76Cr 4.71Cr 322.71Cr 4.74Cr 33Cr 13Cr 164.92Cr 13Cr 13Cr 531.13Cr P/E 2024
-20.9x
P/E 2025 -22.6x
Enterprise Value 2.45Cr 3.32Cr 2.85Cr 2.68Cr 4.57Cr 313.65Cr 4.61Cr 32Cr 12Cr 160.29Cr 12Cr 12Cr 516.22Cr EV / Sales 2024
17x
EV / Sales 2025 7.62x
Free-Float
79.16%
Yield 2024 *
-
Yield 2025 -
1 day-2.33%
1 week+2.44%
1 month-4.55%
3 months-4.55%
6 months-20.75%
Current year+16.67%
1 week 0.93
Extreme 0.9267
1.2
1 month 0.93
Extreme 0.9267
1.25
Current year 0.77
Extreme 0.77
1.55
1 year 0.55
Extreme 0.55
1.55
3 years 0.4
Extreme 0.4
1.55
5 years 0.4
Extreme 0.4
1.55
10 years 0.2
Extreme 0.2
1.55
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer 52 01/01/2000
Director TitleAgeSince
Chairman 79 01/06/2005
Director/Board Member - 11/11/2010
Director/Board Member 52 12/04/2019
Date Insider Type Main position Quantity % Market Cap. Importance
07/01/25 Free

Chief Executive Officer

3,00,00,000 1.2788%
24/01/23 Free

Chief Executive Officer

1,70,00,000 0.7665%
24/01/23 Free

Chief Technology Officer

1,70,00,000 0.7665%
Change 5-day change 1-year change 3-year change Capi.($)
-2.33%+2.44%+42.86%+61.54% 3.33Cr
+0.26%-0.89%+10.46%+64.33% 1.22TCr
-0.58%-5.77%-21.48%+257.01% 916.84Cr
-0.31%-0.81%-17.58%-49.69% 243.06Cr
-1.34%-4.02%-20.01%-8.92% 147.32Cr
+0.02%-0.63%+21.42%+75.67% 136.65Cr
+0.08%-1.46%+22.56%-20.97% 127.55Cr
-2.99%+1.36%-75.16%-74.87% 120.93Cr
-2.89%+4.44%-36.83% - 116.2Cr
+1.86%+12.54%-59.91%-68.24% 101.64Cr
Average -0.82%+1.08%-13.37%+26.21% 313.38Cr
Weighted average by Cap. -0.32%-0.47%-8.83%+96.97%

Financials

2024 2025
Net sales 8L 10.86L 9L 9L 14.97L 10Cr 15.09L 1.04Cr 40.38L 5.24Cr 40.77L 39.88L 17Cr 12.92L 17.49L 15.05L 14.12L 24.12L 17Cr 24.31L 1.67Cr 65.07L 8.45Cr 65.69L 64.26L 27Cr
Net income -6L -8L -7L -6L -10.94L -7.5Cr -11.03L -75.8L -29.52L -3.83Cr -29.8L -29.15L -12Cr -5L -6L -5L -5L -8L -5.79Cr -9L -58.54L -22.8L -2.96Cr -23.01L -22.51L -9.53Cr
Net Debt -2L -3L -2L -2L -4L -2.42Cr -4L -24.48L -10L -1.24Cr -10L -9L -3.99Cr -7L -10L -8L -8L -13.22L -9.06Cr -13.32L -91.55L -35.65L -4.63Cr -35.99L -35.21L -15Cr
Logo Provexis plc
Provexis plc is a United Kingdom-based company that develops, licenses and sells the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available as a spray-dried powder, and it can be included in a broad range of food, beverage and dietary supplement formats. Fruittflow is a highly concentrated form of bioactives which is lycopene-free and contains over 30 known antiplatelet compounds. The Company also offers Fruitflow+, Omega-3, and dietary supplement products which are sold directly to consumers. In addition, the Company supplies Fruitflow as an ingredient to brand owners in the food, beverage, and supplement sectors through DSM Nutritional Products’ distribution network.
Employees
2
Date Price Change Volume
03/26/03 GBX 1.050 -2.33% 25,000
02/26/02 GBX 1.075 +2.38% 1,59,336
01/26/01 GBX 1.050 0.00% 11,672
28/26/28 GBX 1.050 +2.44% 84,031
27/26/27 GBX 1.025 +0.49% 35,45,867